1 – 10 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Plasma levels of PRO-C3, a type III collagen synthesis marker, are associated with arterial stiffness and increased risk of cardiovascular death
(
- Contribution to journal › Article
- 2023
-
Mark
Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
(
- Contribution to journal › Article
-
Mark
Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk
(
- Contribution to journal › Article
-
Mark
Spatial Transcriptional Mapping Reveals Site-Specific Pathways Underlying Human Atherosclerotic Plaque Rupture
(
- Contribution to journal › Article
-
Mark
Understanding autoimmunity in atherosclerosis paves the way for novel therapies
(
- Contribution to journal › Debate/Note/Editorial
- 2022
-
Mark
Circulating Hepatocyte Growth Factor Reflects Activation of Vascular Repair in Response to Stress
(
- Contribution to journal › Article
-
Mark
Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture-prone atherosclerotic plaques
(
- Contribution to journal › Article
-
Mark
Osteomodulin Gene Expression Is Associated with Plaque Calcification, Stability, and Fewer Cardiovascular Events in the CPIP Cohort
(
- Contribution to journal › Article
- 2021
-
Mark
Soluble CD40 levels in plasma are associated with cardiovascular disease and in carotid plaques with a vulnerable phenotype
(
- Contribution to journal › Article
-
Mark
The novel collagen matrikine, endotrophin, is associated with mortality and cardiovascular events in patients with atherosclerosis
(
- Contribution to journal › Article